| Systematic (IUPAC) name | |
|---|---|
| 3-[3-[[2-hydroxy-3-(1-naphthyloxy)propyl]amino]-3-methyl-butyl]-1H-benzimidazol-2-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 78459-19-5 |
| ATC code | None |
| PubChem | CID 71227 |
| ChemSpider | 64362 |
| UNII | B6CJY5K2ST |
| Chemical data | |
| Formula | C25H29N3O3 |
| Mol. mass | 419.52 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Adimolol (MEN-935) is antihypertensive agent which acts as a non-selective α1-, α2-, and β-adrenergic receptor antagonist.[1]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)